Characteristics of Longitudinal Outcomes for Treatment-Resistant Depression (TRD) Patients From a Specialized TRD Clinic

被引：0
|
作者：
Quach, Darin [1 ]
de Leon, Victoria [1 ]
Barnes, Linda [1 ]
Janski, Al [1 ]
Gott, Britt [1 ]
Kumar, Arun [2 ]
Conway, Charles [1 ]
机构：
[1] Washington Univ, Sch Med St Louis, St Louis, MO USA
[2] LivaNova, London, England
来源：
BIOLOGICAL PSYCHIATRY | 2022年 / 91卷 / 09期
关键词：
Treatment Resistant Depression; Depression; Clinical;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P274
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [41] Good Practice for Treatment-Resistant Depression during SARS CoV-2 outbreak: are ketamine infusions an effective alternative for TRD patients? A case series
    Ragone, N.
    Barbini, B.
    Perrozzi, G.
    Colombo, C.
    EUROPEAN PSYCHIATRY, 2023, 66 : S840 - S840
  • [42] The LILA-study: An observational study comparing the efficacy of lithium vs. lamotrigine as an augmentation strategy for treatment-resistant depression (TRD)
    Schindler, F
    Anghelescu, I
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 40S - 41S
  • [43] A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?
    Schreiber, Shaul
    Keidan, Lee
    Pick, Chaim G.
    PHARMACEUTICALS, 2025, 18 (02)
  • [44] Modulating neuroplasticity through synergistic ketamine and accelerated sequential theta burst stimulation (TBS) for treatment-resistant depression (TRD) - A case report
    Ramesh, Veena
    Shamanna, Varsha
    Pathak, Harsh
    Nayok, Swarna Buddha
    Bose, Anushree
    Sreeraj, Vanteemar S.
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 102
  • [45] Neurocognitive characteristics of patients with and without treatment-resistant depression
    Serafini, G.
    Pompili, M.
    Girardi, P.
    Amore, M.
    EUROPEAN PSYCHIATRY, 2018, 48 : S280 - S280
  • [46] Neurocognitive Predictors of Response in Treatment Resistant Depression (TRD) with Deep Brain Stimulation (DBS) Therapy
    McInerney, Shane J.
    McNeely, Heather E.
    Geraci, Joseph
    Giacobbe, Peter
    Rizvi, Sakina J.
    Cyriac, Anna
    Mayberg, Helen
    Lozano, Andres M.
    Kennedy, Sidney H.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 74S - 74S
  • [47] Inflammation, Thyroid Hormone Metabolism, and Treatment Outcome, Among Patients With Treatment Resistant Depression (TRD) Naturalistically Treated With Ketamine or ECT
    Kruse, Jennifer
    Bianco, Antonio
    Espinoza, Randall
    Narr, Katherine
    Irwin, Michael
    BIOLOGICAL PSYCHIATRY, 2023, 93 (09) : S23 - S23
  • [48] TREATMENT-RESISTANT DEPRESSION - CLINICAL CHARACTERISTICS
    DUNNER, DL
    NELSEN, MR
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 617 - 617
  • [49] Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
    Fava, Maurizio
    Freeman, Marlene P.
    Flynn, Martina
    Judge, Heidi
    Hoeppner, Bettina B.
    Cusin, Cristina
    Ionescu, Dawn F.
    Mathew, Sanjay J.
    Chang, Lee C.
    Iosifescu, Dan V.
    Murrough, James
    Debattista, Charles
    Schatzberg, Alan F.
    Trivedi, Madhukar H.
    Jha, Manish K.
    Sanacora, Gerard
    Wilkinson, Samuel T.
    Papakostas, George I.
    MOLECULAR PSYCHIATRY, 2020, 25 (07) : 1592 - 1603
  • [50] Clinical outcomes of a treatment-resistant schizophrenia specialized unit
    Cabacos, C.
    Magano, S.
    Pires, A. C.
    Araujo, A. I.
    Mota, D.
    Mendes, A.
    Bajouco, A.
    Bajouco, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S577 - S578
12345